LYPD3 and non-small cell lung carcinoma: High mRNA expression of six of the NSCLC markers (CA9, CA12, CXorf61, GPR87, LYPD3 and SLC7A11) correlated with decreased patient survival (Table 7, and Figures 6 and 7).